U-BX TECHNOLOGY-A (UBXG) Fundamental Analysis & Valuation
NASDAQ:UBXG • KYG9161K1123
Current stock price
3.34 USD
+1.77 (+112.63%)
At close:
2.3 USD
-1.04 (-31.14%)
After Hours:
This UBXG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. UBXG Profitability Analysis
1.1 Basic Checks
- In the past year UBXG has reported negative net income.
- UBXG had a negative operating cash flow in the past year.
- In the past 5 years UBXG reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: UBXG reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of -11.31%, UBXG is not doing good in the industry: 70.45% of the companies in the same industry are doing better.
- UBXG has a worse Return On Equity (-12.47%) than 60.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.31% | ||
| ROE | -12.47% | ||
| ROIC | N/A |
ROA(3y)-4.39%
ROA(5y)-2.76%
ROE(3y)-0.16%
ROE(5y)-3.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 0.98%, UBXG is not doing good in the industry: 92.05% of the companies in the same industry are doing better.
- UBXG's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for UBXG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 0.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5Y16.68%
2. UBXG Health Analysis
2.1 Basic Checks
- UBXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for UBXG has been increased compared to 1 year ago.
- Compared to 5 years ago, UBXG has more shares outstanding
- UBXG has a better debt/assets ratio than last year.
2.2 Solvency
- UBXG has an Altman-Z score of 16.79. This indicates that UBXG is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 16.79, UBXG belongs to the best of the industry, outperforming 97.73% of the companies in the same industry.
- UBXG has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
- UBXG's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. UBXG outperforms 78.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 16.79 |
ROIC/WACCN/A
WACC7.77%
2.3 Liquidity
- A Current Ratio of 10.24 indicates that UBXG has no problem at all paying its short term obligations.
- UBXG has a better Current ratio (10.24) than 97.73% of its industry peers.
- A Quick Ratio of 10.24 indicates that UBXG has no problem at all paying its short term obligations.
- UBXG has a better Quick ratio (10.24) than 97.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.24 | ||
| Quick Ratio | 10.24 |
3. UBXG Growth Analysis
3.1 Past
- UBXG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.46%, which is quite impressive.
- The Revenue for UBXG has decreased by -41.94% in the past year. This is quite bad
- UBXG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.58% yearly.
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.42%
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-30.04%
Revenue growth 5Y-13.58%
Sales Q2Q%-42.49%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. UBXG Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for UBXG. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. UBXG Dividend Analysis
5.1 Amount
- UBXG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
UBXG Fundamentals: All Metrics, Ratios and Statistics
3.34
+1.77 (+112.63%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.58%
Inst Owner ChangeN/A
Ins Owners34.17%
Ins Owner ChangeN/A
Market Cap101.14M
Revenue(TTM)46.96M
Net Income(TTM)-2.37M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio14.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.32 | ||
| P/tB | 5.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.55
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.31% | ||
| ROE | -12.47% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 0.98% | ||
| FCFM | N/A |
ROA(3y)-4.39%
ROA(5y)-2.76%
ROE(3y)-0.16%
ROE(5y)-3.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5Y16.68%
F-Score2
Asset Turnover2.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 49007.6% | ||
| Cap/Sales | 12.31% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.24 | ||
| Quick Ratio | 10.24 | ||
| Altman-Z | 16.79 |
F-Score2
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)16439.3%
Cap/Depr(5y)9922.48%
Cap/Sales(3y)6.51%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-30.04%
Revenue growth 5Y-13.58%
Sales Q2Q%-42.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-215.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-529.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.48%
OCF growth 3YN/A
OCF growth 5YN/A
U-BX TECHNOLOGY-A / UBXG Fundamental Analysis FAQ
What is the ChartMill fundamental rating of U-BX TECHNOLOGY-A (UBXG) stock?
ChartMill assigns a fundamental rating of 2 / 10 to UBXG.
Can you provide the valuation status for U-BX TECHNOLOGY-A?
ChartMill assigns a valuation rating of 0 / 10 to U-BX TECHNOLOGY-A (UBXG). This can be considered as Overvalued.
Can you provide the profitability details for U-BX TECHNOLOGY-A?
U-BX TECHNOLOGY-A (UBXG) has a profitability rating of 1 / 10.